Repare Therapeutics Statistics
Total Valuation
RPTX has a market cap or net worth of $68.31 million. The enterprise value is -$40.52 million.
Important Dates
The last earnings date was Friday, August 8, 2025, before market open.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RPTX has 42.96 million shares outstanding. The number of shares has increased by 0.92% in one year.
Current Share Class | 42.96M |
Shares Outstanding | 42.96M |
Shares Change (YoY) | +0.92% |
Shares Change (QoQ) | +0.78% |
Owned by Insiders (%) | 1.16% |
Owned by Institutions (%) | 26.97% |
Float | 22.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 271.10 |
Forward PS | n/a |
PB Ratio | 0.62 |
P/TBV Ratio | 0.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.30, with a Debt / Equity ratio of 0.01.
Current Ratio | 6.30 |
Quick Ratio | 6.18 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.96% and return on invested capital (ROIC) is -44.82%.
Return on Equity (ROE) | -69.96% |
Return on Assets (ROA) | -38.82% |
Return on Invested Capital (ROIC) | -44.82% |
Return on Capital Employed (ROCE) | -102.91% |
Revenue Per Employee | $1,938 |
Profits Per Employee | -$851,659 |
Employee Count | 129 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RPTX has paid $1.10 million in taxes.
Income Tax | 1.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.04% in the last 52 weeks. The beta is 0.93, so RPTX's price volatility has been similar to the market average.
Beta (5Y) | 0.93 |
52-Week Price Change | -48.04% |
50-Day Moving Average | 1.49 |
200-Day Moving Average | 1.66 |
Relative Strength Index (RSI) | 61.47 |
Average Volume (20 Days) | 145,919 |
Short Selling Information
The latest short interest is 685,463, so 1.60% of the outstanding shares have been sold short.
Short Interest | 685,463 |
Short Previous Month | 561,427 |
Short % of Shares Out | 1.60% |
Short % of Float | 3.02% |
Short Ratio (days to cover) | 1.07 |
Income Statement
In the last 12 months, RPTX had revenue of $250,000 and -$109.86 million in losses. Loss per share was -$2.58.
Revenue | 250,000 |
Gross Profit | 15.36M |
Operating Income | -113.63M |
Pretax Income | -83.68M |
Net Income | -109.86M |
EBITDA | -110.47M |
EBIT | -113.63M |
Loss Per Share | -$2.58 |
Full Income Statement Balance Sheet
The company has $109.47 million in cash and $649,000 in debt, giving a net cash position of $108.82 million or $2.53 per share.
Cash & Cash Equivalents | 109.47M |
Total Debt | 649,000 |
Net Cash | 108.82M |
Net Cash Per Share | $2.53 |
Equity (Book Value) | 110.41M |
Book Value Per Share | 2.57 |
Working Capital | 106.49M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -103.34M |
Capital Expenditures | n/a |
Free Cash Flow | -103.34M |
FCF Per Share | -$2.41 |
Full Cash Flow Statement Margins
Gross Margin | 6,145.60% |
Operating Margin | -45,450.00% |
Pretax Margin | -43,504.40% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RPTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.92% |
Shareholder Yield | -0.92% |
Earnings Yield | -160.84% |
FCF Yield | -151.29% |
Analyst Forecast
The average price target for RPTX is $4.50, which is 183.02% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.50 |
Price Target Difference | 183.02% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RPTX has an Altman Z-Score of -4.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.06 |
Piotroski F-Score | 2 |